Castaldi Gianluca, Matetić Andrija, Bagur Rodrigo, Abbott J D, Alasnag Mirvat, Chieffo Alaide, Wijeysundera Harindra C, Mamas Mamas A
Department of Cardiovascular Medicine University Hospital Leuven Belgium.
Department of Cardiology University Hospital of Split Croatia.
J Am Heart Assoc. 2025 May 20;14(10):e038463. doi: 10.1161/JAHA.124.038463. Epub 2025 May 15.
Referral for valve intervention for severe aortic stenosis (AS) may exhibit sex-associated disparities independent of the growth of transcatheter interventions. This study aimed to determine whether there were sex-associated differences in the use of aortic valve replacement (AVR), either surgical or transcatheter, in patients with aortic stenosis and severe features from a national cohort of patients.
Using the National Readmission Database, all patients with an index diagnosis of AS between January 2015 and December 2019 were included and stratified by their 90-day readmission status and sex. AS with severe features was defined as the combination of primary- or secondary-coded diagnosis of AS in combination with heart failure, syncope, angina pectoris, cardiac arrest, or cardiogenic shock. A 1:1 nested case-control matching was performed to account for competing risk. The main investigated outcome was the sex-associated rate of AVR in the 90 days after index hospitalization.
A total of 31 712 matched weighted discharges were included in the analysis, 16 597 men (52.3%) and 15 116 women (47.7%). At 90 days, the rate of AVR was significantly lower in women (45.7% versus 53.6%, <0.001) with significant difference for both surgical (<0.001) and transcatheter (=0.010) interventions. After multivariable adjustment, these differences persisted with women significantly less likely to receive AVR (adjusted odds ratio [aOR], 0.67 [95% CI, 0.63-0.71], <0.001), either surgical AVR (aOR, 0.48 [95% CI, 0.43-0.54], <0.001) or transcatheter aortic valve implantation (aOR, 0.79 [95% CI, 0.75-0.84], <0.001).
The use of surgical AVR and transcatheter aortic valve implantation was significantly lower in female patients with AS and severe features independent from patient- and hospital-level characteristics.
对于严重主动脉瓣狭窄(AS)的瓣膜干预转诊可能存在与性别相关的差异,且与经导管干预的发展无关。本研究旨在确定在一个全国性患者队列中,患有主动脉狭窄且有严重特征的患者在接受外科或经导管主动脉瓣置换术(AVR)方面是否存在与性别相关的差异。
利用国家再入院数据库,纳入2015年1月至2019年12月期间初次诊断为AS的所有患者,并根据其90天再入院状态和性别进行分层。具有严重特征的AS被定义为原发性或继发性编码诊断的AS与心力衰竭、晕厥、心绞痛、心脏骤停或心源性休克相结合。进行1:1巢式病例对照匹配以考虑竞争风险。主要研究结局是初次住院后90天内与性别相关的AVR率。
分析共纳入31712例匹配加权出院病例,其中男性16597例(52.3%),女性15116例(47.7%)。在90天时,女性的AVR率显著低于男性(45.7%对53.6%,<0.001),外科干预(<0.001)和经导管干预(=0.010)均存在显著差异。多变量调整后,这些差异仍然存在,女性接受AVR的可能性显著降低(调整后的优势比[aOR],0.67[95%CI,0.63 - 0.71],<0.001),无论是外科AVR(aOR,0.48[95%CI,0.43 - 0.54],<0.001)还是经导管主动脉瓣植入术(aOR,0.79[95%CI,0.75 - 0.84],<0.001)。
在患有AS且有严重特征且独立于患者和医院层面特征的女性患者中,外科AVR和经导管主动脉瓣植入术的使用率显著较低。